A combination of beta‐sitosterol and beta‐sitosterol glucoside and normal function of the immune system: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

A combination of beta‐sitosterol and beta‐sitosterol glucoside and normal function of the immune system: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Abstract Following an application from Essential Sterolin Products (Pty) Ltd., submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of the Netherlands, the European Food Safety Authority (EFSA) Panel on Nutrition, Novel F...

Full description

Bibliographic Details
Main Authors: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Jacqueline Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch‐Ernst, John Kearney, Helle Katrine Knutsen, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Carmen Pelaez, Kristina Pentieva, Frank Thies, Sophia Tsabouri, Marco Vinceti, Jean‐Louis Bresson, Alfonso Siani
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:EFSA Journal
Subjects:
beta‐sitosterol
beta‐sitosterol glucoside
immune system
health claim
Online Access:https://doi.org/10.2903/j.efsa.2019.5776

Internet

https://doi.org/10.2903/j.efsa.2019.5776

Similar Items